Enveric Biosciences Inc vs United States Natural Gas Fund — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while United States Natural Gas Fund trades at $10.56. Which is the better fit depends on your goals.
| ENVB | UNG | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Commodities - Energy |
52-Week High | $17.40 | $16.90 |
52-Week Low | $1.28 | $10.15 |
Enterprise Value | $408.82K | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
UNG, the United States Natural Gas Fund, trades at $10.555 with a modest 0.33% daily gain, while technical indicators signal a bearish trend with 17 sell signals versus 4 buys. The fund's price action remains heavily influenced by natural gas futures, with recent news highlighting volatility tied to weather forecasts, LNG export flows, and weekly storage reports. Key financial ratios are unavailable as this is an exchange-traded fund tracking commodity futures rather than a traditional company with revenue and earnings.
The outlook for UNG remains challenging due to structural contango in futures markets, which has historically eroded long-term returns. While short-term price movements offer trading opportunities based on weather and demand fluctuations, the fund faces significant headwinds from ample storage and production levels. Investors should recognize this as a speculative trading vehicle rather than a long-term investment.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →